Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.
The team hope the compound –developed after 10 years of painstaking research will be trialled on humans within three to four years.
The drug- which works by targeting Mycobacterium tuberculosis’ defences rather than the bacteria itself – can also take out its increasingly commonly antibiotic resistant strains.
The research funded by the Medical Research Council – is published today in the Journal of Medicinal Chemistry.
Although a vaccine for TB was developed 100 years ago, one in three people across the world are thought to be infected with the infectious disease.
About 1.7 million die from the bug each year worldwide and 7.3 million people were diagnosed and treated in 2018, up from the 6.3 million in 2016.
It is most common in Africa, India and China, but on the rise in the UK with London often described as the TB capital of Europe.
Patients are forced to take a cocktail of strong antibiotics over 6 to 8 months, often enduring unpleasant side effects with a 20% risk that the disease will return.
But now The University of Manchester team’s discovery has been proven effective in guinea pigs at Rutgers University in the United States.
The animals with acute and chronic TB infection were treated with the compound, which was discovered after investigating dozens of other derivatives and compounds thought to have similar properties.
Professor Lydia Tabernero is the project leader. She said: “The fact that the animal studies showed our compound, which doesn’t kill the bacteria directly, resulted in a significant reduction in the bacterial burden is remarkable.
“For more than 60 years, the only weapon doctors have been able to use against TB is antibiotics. But resistance is becoming an increasingly worrying problem and the prolonged treatment is difficult and distressing for patients.
“And with current treatments, there’s no guarantee the disease will be eliminated: antibiotics do not clear the infection and the risk of being infected with drug-resistant bacteria is very high.
“But by disabling this clandestine bacteria’s defences we’re thrilled to find a way that enhances the chances of the body’s immune system to do its job, and thus eliminate the pathogen.”
Mycobacterium Tuberculosis secretes molecules called Virulence Factors – the cell’s secret weapon -which block out the immune response to the infection, making it difficult to treat.
The team identified one Virulence Factor called MptpB as a suitable target, which when blocked allows white blood cells to kill Mycobacterium Tuberculosis in a more efficient way
Professor Tabernero added: “The great thing about MptpB is that there’s nothing similar in humans – so our compound which blocks it is not toxic to the human cells.
“Because the bacteria hasn’t been threatened directly, it is less likely to develop resistance against this new agent, and this will be a major advantage over current antibiotics, for which bacteria had already become resistant.
“TB is an amazingly difficult disease to treat so we feel this is a significant breakthrough.
”The next stage of our research is to optimise further the chemical compound, but we hope clinical trials are up to four years away.”
Learn more: Scientists develop new drug treatment for TB
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- Polymorphisms of cytokine genes and tuberculosis in two independent studies on February 22, 2019 at 1:36 am
Linkage disequilibrium (LD) of cytokine gene SNPs in the both Han (above) and Tibetan (below) populations. LD r2 values (ranging from 0 to 1) for all pairs of SNPs are presented as percentages. Shadin... […]
- Tuberculosis patients more likely to continue treatment administered via smartphone app on February 21, 2019 at 3:30 pm
Tuberculosis (TB) patients are more likely to continue drug treatment administered over smartphone than through face-to-face appointments, a study has found. Researchers from University College London ... […]
- IDRI partners with Afrigen Biologics and Biovac to produce tuberculosis vaccine on February 21, 2019 at 1:24 pm
In an effort to produce vaccines where they are needed most, IDRI (Infectious Disease Research Institute) is collaborating with the Cape Town, South Africa, based biotechnology startup company Afrigen ... […]
- University of Missouri reports tuberculosis case on campus on February 19, 2019 at 11:43 am
COLUMBIA, Mo. (AP) — The University of Missouri says a student has been diagnosed with active tuberculosis and left campus voluntarily. The school said in a news release that campus and local health o... […]
- Student diagnosed with active tuberculosis at University of Missouri on February 18, 2019 at 7:28 pm
Feb. 18--COLUMBIA, Mo. — University of Missouri officials announced Monday that a student has been diagnosed with active tuberculosis. Load Error The university said the student has voluntarily left t... […]
- Researchers identify suicide toxin in the bacteria responsible for tuberculosis on February 18, 2019 at 6:50 pm
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein. The European team of scientists behind this discovery is coordinated by ... […]
- MU student diagnosed with tuberculosis on February 18, 2019 at 1:35 pm
COLUMBIA — An unidentified MU student has been diagnosed with active tuberculosis, the university confirmed in a news release on Monday. The student has voluntarily left campus. "The student has been ... […]
- Missouri student on Columbia campus has active tuberculosis on February 18, 2019 at 1:20 pm
COLUMBIA, Mo. (AP) — University of Missouri officials say a student on the Columbia campus has active tuberculosis and may have infected other people. The school announced Monday that the Boone County ... […]
- Mizzou student has active tuberculosis, school officials say on February 18, 2019 at 12:16 pm
A student at the University of Missouri in Columbia has active tuberculosis and possibly infected others, school officials announced Monday. School officials are investigating the case with the Boone ... […]
via Bing News